Interleukins in cancer: from biology to therapy

2021/06/03 by Daria Briukhovetska, Janina Dörr, Stefan Endres +3 · 8 citations
Immunology and Microbiology · #Immune Cell Function and Interaction #Immune cells in cancer #Immunotherapy and Immune Responses

paper · pdf · doi:10.1038/s41568-021-00363-z

crossref issued 2021/06/03 · crossref published 2021/06/03 · crossref published-online 2021/06/03 · openalex publication_date 2021/06/03 · crossref created 2021/06/03 · crossref published-print 2021/08/01 · crossref deposited 2024/12/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30 · crossref indexed 2026/07/31

Citations

• IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression

Cited by

• P-stalk ribosomes act as master regulators of cytokine-mediated processes
• RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
• Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy
• Harnessing the immune system and developing targeted vaccines: overall strategies of leveraging the body’s natural defense mechanisms to enhance cancer treatment
• Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs
• Overcoming cancer immunotherapy barriers via nanomaterial-mediated pyroptosis
• Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer
• Interleukin-8 in health and disease